Daly Richard J 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Aug 28, 2025
Insider Transaction Report
Form 4
Daly Richard J
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common stock, par value $0.001 per share
2025-08-26$2.24/sh+50,000$112,000→ 249,764 total - Exercise/Conversion
Options to purchase common stock
2025-08-26−50,000→ 2,184,753 totalExercise: $2.24Exp: 2025-12-19→ Common Stock (50,000 underlying) - Sale
Common stock, par value $0.001 per share
2025-08-26$20.62/sh−22,970$473,641→ 226,794 total
Footnotes (2)
- [F1]Shares were sold on the open market to fund the exercise price and tax withholding due from Mr. Daly on the exercise of the 50,000 stock options reported on Table II.
- [F2]Derivative securities vested in three annual tranches beginning on December 19, 2019.